Cleared Special

LV Liberty Vision Model 1 90Yttrium Brachytherapy Source

K193602 · Lv Liberty Vision Corporation · Radiology
May 2020
Decision
158d
Days
Class 2
Risk

About This 510(k) Submission

K193602 is an FDA 510(k) clearance for the LV Liberty Vision Model 1 90Yttrium Brachytherapy Source, a Source, Brachytherapy, Radionuclide (Class II — Special Controls, product code KXK), submitted by Lv Liberty Vision Corporation (Portsmouth, US). The FDA issued a Cleared decision on May 29, 2020, 158 days after receiving the submission on December 23, 2019. This device falls under the Radiology review panel. Regulated under 21 CFR 892.5730.

Submission Details

510(k) Number K193602 FDA.gov
FDA Decision Cleared SESE
Date Received December 23, 2019
Decision Date May 29, 2020
Days to Decision 158 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code KXK — Source, Brachytherapy, Radionuclide
Device Class Class II — Special Controls
CFR Regulation 21 CFR 892.5730

Similar Devices — KXK Source, Brachytherapy, Radionuclide

All 150
OncoPatch
K252296 · Oncopatch, Inc. · Dec 2025
IsoSphere
K242818 · Isoaid, LLC · Jul 2025
RadianceTx Radionuclide Brachytherapy Source
K223465 · Radiance Therapeutics, Inc. · Jan 2023
GammaTile
K221539 · Gt Medical Technologies · Nov 2022
Sirius MRI Markers, Cs-131 Preloaded Strands with Sirius MRI Markers in 18 Gauge Needles
K202267 · Isoray Medical, Inc. · Dec 2020
GammaTile
K190839 · Gt Medical Technologies · Jan 2020